Literature DB >> 8907173

Acylation of the alpha-amino group in neuropeptide Y(12-36) increases binding affinity for the Y2 receptor.

S Murase1, N Yumoto, M G Petukhov, S Yoshikawa.   

Abstract

Competition assays using three series of analogs of neuropeptide Y (NPY) ([Xaa11]NPY(11-36), [Xaa12]NPY(12-36), and [Xaa13]NPY(13-36) revealed that the binding affinity for the Y2 receptor was considerably lowered by truncation of residue 11. Upon acetylation or succinylation of the alpha-amino group, the binding affinity of [Xaa12]NPY(12-36) recovered to a level similar to that of [Xaa11]NPY(11-36). No significant difference was observed between the increases caused by acetylation and those caused by succinylation, suggesting that the increase in binding affinity cannot be explained by the change in the net charge at the N-terminus as a consequence of the modification. The scattered data points on a plot of the alpha-helix content vs. IC50 of all these analogs revealed the absence of any apparent relationship, an indication that prior formation of the alpha-helix is not necessary for binding to the Y2 receptor. It has been widely accepted that fewer than 12 residues from the C-terminus are directly involved in binding of NPY to the Y2 receptor, while the remaining part of NPY only assists in the adoption of a favorable conformation by the C-terminal hexapeptide for recognition by the receptor. However, the present results suggest that the region around residue 12 does not project from the Y2 receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8907173     DOI: 10.1093/oxfordjournals.jbchem.a021213

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation.

Authors:  M Shimizu; Y Shigeri; Y Tatsu; S Yoshikawa; N Yumoto
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

2.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

3.  Acylation of exenatide by glycolic acid and its anti-diabetic activities in db/db mice.

Authors:  Rongcai Liang; Xiang Li; Renyu Zhang; Yanan Shi; Aiping Wang; Daquan Chen; Kaoxiang Sun; Wanhui Liu; Youxin Li
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

4.  Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.

Authors:  Ying Zhang; Andreas M Sophocleous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2009-06-16       Impact factor: 4.200

5.  Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.

Authors:  David Chatenet; Renzo Cescato; Beatrice Waser; Judit Erchegyi; Jean E Rivier; Jean Claude Reubi
Journal:  EJNMMI Res       Date:  2011-09-02       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.